Page URL:

Genetic clues to pre-eclampsia

15 October 2004
By BioNews
Appeared in BioNews 280

Certain combinations of maternal and fetal genes might increase the risk of pre-eclampsia, the most common serious complication of pregnancy, UK scientists say.

The researchers, based at Cambridge University, think some genetic variations that affect the mother's immune system could influence the supply of nutrients to the developing fetus. The findings, published in the Journal of Experimental Medicine, could eventually lead to a screening test to identify pregnant women at risk of the condition, say the team.

Pre-eclampsia usually arises during the second half of pregnancy. It can cause high blood pressure, liver problems, blood abnormalities, slow fetal growth and, if untreated, can lead to life-threatening seizures in the mother. Because the only way to 'treat' pre-eclampsia is to deliver the baby, the condition is a major reason for premature births and their associated health problems. The causes of pre-eclampsia are unknown, although some scientists think that it could be triggered by the mother's immune system attacking the fetal cells that form the placenta. The condition runs in families, suggesting that genes are involved, but other factors are also thought to play a role.

In the latest study, the researchers looked at DNA from 200 pregnant women who had pre-eclampsia and 201 expectant mothers who did not have the condition. They focussed on a gene that makes a key immune system protein, called KIR, which is crucial to setting up the placenta's blood supply. In a healthy pregnancy, fetal cells called trophoblasts do this by 'invading' the uterus, while communicating with maternal immune cells. The scientists found that women who had two copies of the 'A' version of the KIR gene had an increased risk of pre-eclampsia, but only if a particular genetic variation affecting a protein on the surface of the fetal trophoblast cells was also present.

The study suggests that genetic factors could trigger pre-eclampsia, by causing a 'communication breakdown' between the mother's cells and the fetal cells that make the placenta. Team leader Ashley Moffett stresses that 'miles more research is needed', but adds that 'this is the first hint that certain gene combinations between the mother and the baby will make some women at risk'. Mike Rich, of the charity Action on Pre-Eclampsia, welcomed the research, telling BBC News Online that 'the development of a test which could identify those women more at risk would have a significant effect on the management of pre-eclampsia'.

Clues to cause of Pre-eclampsia found
Medical News Today |  12 October 2004
Clue to pregnancy disorder found
BBC News Online |  11 October 2004
Genetic link to Preeclampsia, a serious complication of pregnancy
News-Medical |  11 October 2004
Maternal and fetal genes in pre-eclampsia
PHGU Newsletter October 2004 |  13 October 2004
28 March 2011 - by Owen Clark 
A study has linked mutations in three genes with the severe pregnancy condition, pre-eclampsia. The international research team say they're the first to link genetic mutations and pre-eclampsia in women with the autoimmune disorder lupus...
21 February 2011 - by Dr Lucy Freem 
A gene important in autoimmune disease has been linked to pre-eclampsia, a serious complication of pregnancy. The study from scientists at North Carolina State University looked at the genes that are switched on and off in the human placenta, to find genes that are differently expressed in pre-eclampsia...
19 September 2005 - by BioNews 
Men and women born following a pregnancy affected by pre-eclampsia can both pass an increased risk of the condition on to the next generation, a Norwegian study has found. Scientists at the University of Bergen used data from the country's birth registry to show that daughters of women affected by...
8 April 2005 - by BioNews 
Dutch researchers have identified a faulty gene that causes pre-eclampsia in some families affected by the disease. Scientists at the VU University Medical Centre in Amsterdam say the identification of the gene, dubbed STOX1, could lead to new tests for the condition. Women at risk could then be given preventative...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.